Class II · Moderate risk
Buprenorphine HCl
Crystallization; identified as Buprenorphine free base
National Drug Code
Is NDC 42023-0179-05 recalled?
Buprenorphine Hydrochloride · 5 VIAL in 1 CARTON (42023-179-05) / 1 mL in 1 VIAL
Yes — this exact package was recalled
4 FDA recalls name the code 42023-0179-05 directly. A recall still applies to particular lot numbers — compare the lot on your package with the FDA notice below, and talk to your pharmacist before stopping a prescribed medication.
2 of these recalls are still ongoing.
- Active ingredient
- Buprenorphine Hydrochloride
- Strength
- BUPRENORPHINE HYDROCHLORIDE .324 mg/mL
- Form
- Injection · Intramuscular, Intravenous
- Labeler
- Par Health USA, LLC
- Type
- Human Prescription Drug · DEA CIII
- Product code
- 42023-0179
Recalls naming this package
Class II · Moderate risk
Buprenorphine Hydrochloride
Crystallization; identified as Buprenorphine free base
Class II · Moderate risk
Buprenorphine HCl
Crystallization; identified as Buprenorphine free base
Class II · Moderate risk
Buprenorphine HCI Injection
Crystallization: due to the presence of white, crystalline particulates, adhered to the side and bottom of the glass vials, which are comprised of principally dextrose and the buprenorphine active component.
Where to find this code. The NDC is printed on the pharmacy label and on the manufacturer's carton, usually as three groups of digits after “NDC”. The last group is the package size — two bottles of the same medicine can differ only in that group, and a recall may cover one but not the other.
Other recalled products from this labeler
- 42023-0103 See recall 1
- 42023-0116 Pitocin 1
- 42023-0159 Adrenalin 1
- 42023-0168 Adrenalin 1
- 42023-0206 See recall 1
- 42023-0237 Vasostrict 1
Free recall alerts
Know the day your medication is recalled
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.